We are live on ! Find out more
EDSA icon

Edesa Biotech
EDSA

22 hedge funds and large institutions have $3.49M invested in Edesa Biotech in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

606% more capital invested

Capital invested by funds: $494K → $3.49M (+$3M)

500% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 1

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

5% more funds holding

Funds holding: 21 → 22 (+1)

0.71% more ownership

Funds ownership: 0.5% → 1.21% (+0.71%)

Holders
22
Holders Change
+1
Holders Change %
+4.76%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
6
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VCIM
Velan Capital Investment Management
Georgia
+$945K
2
LCM
Lynwood Capital Management
Ontario, Canada
+$130K
3
CM
CM Management
Florida
+$66.8K
4
State Street
State Street
Massachusetts
+$21.1K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$16.2K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$16K
2
TRCT
Tower Research Capital (TRC)
New York
-$6.02K
Name Holding Trade Value Shares
Change 		Change in
Stake
VCIM
1
Velan Capital Investment Management
Georgia
$1.92M +$945K +126,984 New
CM
2
CM Management
Florida
$676K +$66.8K +8,968 +25%
LCM
3
Lynwood Capital Management
Ontario, Canada
$264K +$130K +17,406 New
Vanguard Group
4
Vanguard Group
Pennsylvania
$240K +$179 +24 +0.2%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$187K +$4.52K +607 +5%
State Street
6
State Street
Massachusetts
$95K +$21.1K +2,828 +82%
Northern Trust
7
Northern Trust
Illinois
$33.2K – – –
Susquehanna International Group
8
Susquehanna International Group
Pennsylvania
$32.9K +$16.2K +2,173 New
National Bank of Canada
9
National Bank of Canada
Quebec, Canada
$17.2K +$4.26K +572 +100%
TRCT
10
Tower Research Capital (TRC)
New York
$14K -$6.02K -809 -47%
Royal Bank of Canada
11
Royal Bank of Canada
Ontario, Canada
$3K – – –
Morgan Stanley
12
Morgan Stanley
New York
$2.96K +$194 +26 +15%
TWC
13
TD Waterhouse Canada
Ontario, Canada
$2K – – –
Fifth Third Bancorp
14
Fifth Third Bancorp
Ohio
$1.51K – – –
BlackRock
15
BlackRock
New York
$1.12K – – –
FDCDDQ
16
Federation des caisses Desjardins du Quebec
Quebec, Canada
$292 – – –
Wells Fargo
17
Wells Fargo
California
$166 – – –
UBS Group
18
UBS Group
Switzerland
$71 – – –
Dimensional Fund Advisors
19
Dimensional Fund Advisors
Texas
$38 – – –
AWM
20
AllSquare Wealth Management
New York
$22 – – –
Credit Agricole
21
Credit Agricole
France
$19 – – –
Millennium Management
22
Millennium Management
New York
– -$16K -2,555 Closed

EDSA Hedge Fund Activity: Q4 2022 in Review

22 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Edesa Biotech (EDSA) for Q4 2022, worth a combined $3.49M — up 606% from $494K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new EDSA positions and 2 closed out — a net gain of 1 holder — while 6 added to existing stakes and 1 trimmed.

The largest buyer was Velan Capital Investment Management, opening a new position worth an estimated $945K. The largest seller was Millennium Management, exiting entirely with an estimated $16K sold.

  • 22 institutional investors held Edesa Biotech (EDSA) as of Q4 2022, up from 21 in Q3 2022.
  • Funds reported $3.49M of Edesa Biotech stock for Q4 2022, up 606% quarter-over-quarter.
  • 3 funds opened new Edesa Biotech positions in Q4 2022 and 2 closed out, a net change of +1 holder.
  • The largest Edesa Biotech buyer in Q4 2022 was Velan Capital Investment Management, an estimated $945K added.
  • The largest Edesa Biotech seller in Q4 2022 was Millennium Management, an estimated $16K sold.

Based on aggregated 13F filings for Q4 2022.